127 related articles for article (PubMed ID: 7838671)
1. Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line.
Barrett-Jolley R; Byrne N; Vincent A; Newsom-Davis J
Pflugers Arch; 1994 Oct; 428(5-6):492-8. PubMed ID: 7838671
[TBL] [Abstract][Full Text] [Related]
2. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
[TBL] [Abstract][Full Text] [Related]
3. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
Plested CP; Tang T; Spreadbury I; Littleton ET; Kishore U; Vincent A
Neurology; 2002 Dec; 59(11):1682-8. PubMed ID: 12473752
[TBL] [Abstract][Full Text] [Related]
4. Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen.
Somnier FE
J Neuroimmunol; 1994 Apr; 51(1):63-8. PubMed ID: 8157737
[TBL] [Abstract][Full Text] [Related]
5. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
Blaes F; Beeson D; Plested P; Lang B; Vincent A
Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
[TBL] [Abstract][Full Text] [Related]
6. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis.
Li Z; Forester N; Vincent A
J Neuroimmunol; 1996 Feb; 64(2):179-83. PubMed ID: 8632060
[TBL] [Abstract][Full Text] [Related]
7. TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis.
Franciotta D; Martino G; Brambilla E; Zardini E; Locatelli V; Bergami A; Tinelli C; Desina G; Cosi V
Clin Chem; 1999 Mar; 45(3):400-5. PubMed ID: 10053042
[TBL] [Abstract][Full Text] [Related]
8. Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita.
Vincent A; Jacobson L; Plested P; Polizzi A; Tang T; Riemersma S; Newland C; Ghorazian S; Farrar J; MacLennan C; Willcox N; Beeson D; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():482-96. PubMed ID: 9668280
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671.
Voltz R; Hohlfeld R; Fateh-Moghadam A; Witt TN; Wick M; Reimers C; Siegele B; Wekerle H
Neurology; 1991 Nov; 41(11):1836-8. PubMed ID: 1944918
[TBL] [Abstract][Full Text] [Related]
10. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
11. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss.
Guyon T; Wakkach A; Poea S; Mouly V; Klingel-Schmitt I; Levasseur P; Beeson D; Asher O; Tzartos S; Berrih-Aknin S
J Clin Invest; 1998 Jul; 102(1):249-63. PubMed ID: 9649579
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia gravis.
Jahn K; Franke C; Bufler J
Neurology; 2000 Jan; 54(2):474-9. PubMed ID: 10668717
[TBL] [Abstract][Full Text] [Related]
13. A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis.
Beeson D; Jacobson L; Newsom-Davis J; Vincent A
Neurology; 1996 Dec; 47(6):1552-5. PubMed ID: 8960744
[TBL] [Abstract][Full Text] [Related]
14. Multiple antibody detection in 'seronegative' myasthenia gravis patients.
Hong Y; Zisimopoulou P; Trakas N; Karagiorgou K; Stergiou C; Skeie GO; Hao HJ; Gao X; Owe JF; Zhang X; Yue YX; Romi F; Wang Q; Li HF; Gilhus NE; Tzartos SJ
Eur J Neurol; 2017 Jun; 24(6):844-850. PubMed ID: 28470860
[TBL] [Abstract][Full Text] [Related]
15. Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture.
Sideris S; Lagoumintzis G; Kordas G; Kostelidou K; Sotiriadis A; Poulas K; Tzartos SJ
J Neuroimmunol; 2007 Sep; 189(1-2):111-7. PubMed ID: 17617475
[TBL] [Abstract][Full Text] [Related]
16. Seronegative myasthenia gravis.
Vincent A; McConville J; Farrugia ME; Newsom-Davis J
Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
[TBL] [Abstract][Full Text] [Related]
17. Measurement of anti-acetylcholine receptor auto-antibodies in myasthenia gravis.
Steenkamp KJ; Duim W; Myer MS; Malfeld SC; Anderson R
S Afr Med J; 1995 Dec; 85(12):1293-4. PubMed ID: 8600588
[TBL] [Abstract][Full Text] [Related]
18. Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.
Wintzen AR; Plomp JJ; Molenaar PC; van Dijk JG; van Kempen GT; Vos RM; Wokke JH; Vincent A
Ann Neurol; 1998 Oct; 44(4):657-64. PubMed ID: 9778265
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
[TBL] [Abstract][Full Text] [Related]
20. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
Ruff RL; Lennon VA
Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
